Stock Price
6,273.50
Daily Change
-17.50 -0.28%
Monthly
3.59%
Yearly
10.01%
Q1 Forecast
6,171.47

Divis Laboratories Ltd reported INR17.28B in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Alaunos Therapeutics USD 921K 153K Sep/2025
Aurobindo Pharma INR 155.01B 8.18B Sep/2025
Avita Medical AUD 62.6M 42.44M Jun/2025
Dianthus Therapeutics USD 23.86M 3.76M Sep/2025
Divis Laboratories Ltd INR 17.28B 2.76B Sep/2025
Ionis Pharmaceuticals USD 903.46M 6.22M Sep/2025
IQVIA Holdings USD 8.34B 170M Dec/2025
Lupin INR 108.21B 18.59B Sep/2025
Moderna USD 1.99B 306M Dec/2025
Organon & Co USD 2.68B 117M Sep/2025
Revvity USD 1.33B 108.5M Dec/2025
Tectonic Therapeutic USD 9.37M 1.99M Sep/2025
Tilray USD 280.3M 18.13M Mar/2025
Viatris USD 7.36B 230.7M Sep/2025
Xeris Pharmaceuticals USD 116.2M 21.03M Sep/2025